Top Story

VIDEO: Study — Pretreatment with Fovista improves visual results in patients with neovascular

November 28, 2015

LAS VEGAS — At the American Academy of Ophthalmology annual meeting, Pravin Dugel, MD, discusses pilot study data in which vision improved in patients with neovascular age-related macular degeneration who were treatment resistant to anti-VEGF therapy and were then pretreated with Fovista (pegpleranib, Ophthotech).

Meeting News CoverageVideo

VIDEO: Subretinal fluid seen as 'protective' against development of macular atrophy

November 27, 2015
LAS VEGAS — At the American Academy of Ophthalmology annual meeting, Brandon G. Busbee, MD, reports on risk factors associated with development of macular atrophy as…
In the Journals

Researchers: Recognizing presbyopia formally as vision impairment by WHO is essential

November 27, 2015
The late Brien A. Holden, PhD, DSc, OAM, and colleagues recommended formal inclusion of near vision impairment in the World Health Organization’s international…
Meeting News Coverage

Single dose of bimatoprost ocular insert demonstrates IOP reduction in glaucoma, ocular hypertension

November 25, 2015
LAS VEGAS — A single dose of a novel topical bimatoprost ocular insert demonstrated sustained IOP reduction in patients with glaucoma and ocular hypertension at 6…

VIDEO: Grover on evidence-based care in patients with diabetes

November 25, 2015
Lori L. Grover, OD, PhD, dean of the Pennsylvania College of Optometry at Salus University, discusses how the use of systemic medications in patients with diabetes…
More News Headlines »
Meeting News Coverage

Improvements in visual acuity with corneal inlay remain stable long-term

November 16, 2015
NEW ORLEANS – A study involving 253 subjects who received the Kamra corneal inlay in their nondominant eye showed…
More »

Arizona allows sale of adjustable focus eye wear without prescription

October 29, 2015
Arizona now permits the sale of adjustable eye wear without a prescription, based on a ruling by the assistant attorney…
More »

Allergan seeks approval for preservative-free Restasis

November 13, 2015
Allergan announced it has submitted a Prior Approval Supplement for Restasis 0.05% to obtain marketing clearance for a…
More »
Current Issues
View the Current Issue
Primary Care Optometry News